Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy.

Lorefice L, Murgia F, Fenu G, Frau J, Coghe G, Murru MR, Tranquilli S, Visconti A, Marrosu MG, Atzori L, Cocco E.

Neurotherapeutics. 2019 Jul;16(3):797-807. doi: 10.1007/s13311-019-00721-8.

PMID:
30820880
2.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Iannello A, Rolla S, Maglione A, Ferrero G, Bardina V, Inaudi I, De Mercanti S, Novelli F, D'Antuono L, Cardaropoli S, Todros T, Turrini MV, Cordioli C, Puorro G, Marsili A, Lanzillo R, Brescia Morra V, Cordero F, De Bortoli M, Durelli L, Visconti A, Cutrupi S, Clerico M.

Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.

3.

Improved upper bounds for the expected circuit complexity of dense systems of linear equations over GF(2).

Visconti A, Schiavo CV, Peralta R.

Inf Process Lett. 2018;137. doi: 10.1016/j.ipl.2018.04.010.

4.

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

La Rocca C, Carbone F, De Rosa V, Colamatteo A, Galgani M, Perna F, Lanzillo R, Brescia Morra V, Orefice G, Cerillo I, Florio C, Maniscalco GT, Salvetti M, Centonze D, Uccelli A, Longobardi S, Visconti A, Matarese G.

Metabolism. 2017 Dec;77:39-46. doi: 10.1016/j.metabol.2017.08.011. Epub 2017 Sep 8.

5.

Antitumour indolequinones: synthesis and activity against human pancreatic cancer cells.

Inman M, Visconti A, Yan C, Siegel D, Ross D, Moody CJ.

Org Biomol Chem. 2014 Jul 21;12(27):4848-61. doi: 10.1039/c4ob00711e.

6.

[Interview with a patient suffering from hepatitis c].

Visconti A.

Soins. 2013 Nov;(780):52. French. No abstract available.

PMID:
24409622
7.

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M.

Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.

8.

Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta.

Lande R, Gafa V, Serafini B, Giacomini E, Visconti A, Remoli ME, Severa M, Parmentier M, Ristori G, Salvetti M, Aloisi F, Coccia EM.

J Neuropathol Exp Neurol. 2008 May;67(5):388-401. doi: 10.1097/NEN.0b013e31816fc975.

PMID:
18431257
9.

Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis.

Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, Visconti A, Brescianini S, Sepe Monti M, Forte G, Stanzione P, Bocca B, Bomboi G, D'Ippolito C, Annibali V, Salvetti M, Sancesario G.

Neurotoxicology. 2007 May;28(3):450-6. Epub 2006 Dec 9.

PMID:
17267042
10.

Concentration of elements in serum of patients affected by multiple sclerosis with first demyelinating episode: a six-month longitudinal follow-up study.

Visconti A, Cotichini R, Cannoni S, Bocca B, Forte G, Ghazaryan A, Santucci S, D'Ippolito C, Stazi MA, Salvetti M, Alimonti A, Ristori G.

Ann Ist Super Sanita. 2005;41(2):217-22.

11.

Quantification of chemical elements in blood of patients affected by multiple sclerosis.

Forte G, Visconti A, Santucci S, Ghazaryan A, FigĂ -Talamanca L, Cannoni S, Bocca B, Pino A, Violante N, Alimonti A, Salvetti M, Ristori G.

Ann Ist Super Sanita. 2005;41(2):213-6.

Supplemental Content

Loading ...
Support Center